- Featured Product
- KD/KO Validated
RBM47 Polyclonal antibody
RBM47 Polyclonal Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, rat, mouse
Applications
WB, IP, ELISA
Conjugate
Unconjugated
Cat no : 23902-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | A549 cells, rat lung tissue |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
KD/KO | See 1 publications below |
WB | See 3 publications below |
IP | See 1 publications below |
Product Information
The immunogen of 23902-1-AP is RBM47 Fusion Protein expressed in E. coli.
Tested Reactivity | human, rat, mouse |
Cited Reactivity | human, mouse |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | RBM47 fusion protein Ag20984 |
Full Name | RNA binding motif protein 47 |
Calculated Molecular Weight | 593 aa, 64 kDa |
Observed Molecular Weight | 64 kDa |
GenBank Accession Number | BC126261 |
Gene Symbol | RBM47 |
Gene ID (NCBI) | 54502 |
RRID | AB_2879356 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen Affinity purified |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
Product Specific Protocols | |
---|---|
WB protocol for RBM47 antibody 23902-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Cell Death Discov RBM47 inhibits hepatocellular carcinoma progression by targeting UPF1 as a DNA/RNA regulator.
| ||
Apoptosis Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells | ||
Korean J Physiol Pharmacol Curcumin modulates the apolipoprotein B mRNA editing by coordinating the expression of cytidine deamination to uridine editosome components in primary mouse hepatocytes. |